Covered recipient · General Payments record
NADARAJAH NIRMALAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,609.76
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $223.76 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $98.36 | 4 |
| Acerta Pharma LLC | $62.79 | 3 |
| Novo Nordisk AS | $41.79 | 2 |
| Sumitomo Pharma America, Inc. | $20.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.75 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105128727 | CMS |
| ABBVIE INC. | $26.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105128729 | CMS |
| ABBVIE INC. | $14.03 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105128731 | CMS |
| ABBVIE INC. | $32.70 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105128733 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.47 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104450106 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.90 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104677115 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.42 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105516787 | CMS |
| Novo Nordisk Inc | $19.94 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097096187 | CMS |
| Novo Nordisk Inc | $21.85 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096688908 | CMS |
| Sumitomo Pharma America, Inc. | $20.82 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148897113 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.